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Abstract
Background Intramyocardial cell injections in the context of
cardiac regenerative therapy can currently be performed using
electromechanical mapping (EMM) provided by the
NOGA®XP catheter injection system. The gold standard
technique to determine infarct size and location, however, is
late gadolinium enhanced magnetic resonance imaging (LGE-
MRI). In this article we describe a practical and accurate
technique to co-register LGE-MRI and NOGA®XP datasets
during the injection procedures to ultimately perform image-
guided injections to the border zone of the infarct determined
by LGE-MRI.
Materials and methods LGE-MRI and EMM were obtained
in three pigs with chronic myocardial infarction. MRI and
EMM datasets were registered using the in-house developed
3D CartBox image registration toolbox consisting of three
steps: 1) landmark registration, 2) surface registration, and 3)
manual optimization. The apex and the coronary ostia were
used as landmarks.
Results Image registration was successful in all datasets, and
resulted in a mean registration error of 3.22±1.86 mm be-
tween the MRI surface mesh and EMM points. Visual assess-
ment revealed that the locations and the transmural extent of
the infarctions measured by LGE-MRI only partly overlap
with the infarct areas identified by the EMM parameters.
Conclusions The 3D CartBox image registration toolbox en-
ables registration of EMM on pre-procedurally acquired MRI
during the catheter injection procedure. This allows the oper-
ator to perform real-time image-guided cell injections into the
border zone of the infarct as assessed by LGE-MRI. The 3D
The questions can be answered after the article has been published in
print. You have to log in to: www.cvoi.nl.
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CartBox thereby enables, for the first time, standardisation of
the injection location for cardiac regenerative therapy.
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Introduction
Previous studies have shown that injection of stem/progenitor
cells into the border zone of the infarcted area in the context of
cardiac regenerative therapy helped to stimulate cardiac repair
and protection via cell-to-cell contact and secretion of paracrine
factors [1–7]. However, therapeutic effects may rely on the
delivery and retention of the regenerative therapeutics on a
location where oxygen and nutrients are available to enable
survival [8]. Hence, accurate identification of viable tissue in
the proximity of the infarct is of great importance. Via
intramyocardial injection catheters stem/progenitor cells or bio-
materials can be injected in a minimally invasive fashion into the
myocardium. Injection locations can be chosen based on tissue
viability measures obtained from electromechanical mapping
(EMM), or a-priori knowledge about the infarct location [9].
The NOGA®XP intramyocardial injection system [10] provides
a three-dimensional (3D) magnetic tracking technology and
allows the assessment of local electrical and mechanical tissue
characteristics. Local unipolar and bipolar depolarisation poten-
tials and relative catheter tip displacements (linear local shorten-
ing) are measured at multiple locations on the left ventricular
endocardium. These measurements are interpolated to obtain a
three-dimensional reconstruction which is used to guide cell
injections. This technique is currently used in clinical practice
[11–16]. Measurements can however not, be performed in re-
gions that are susceptible for arrhythmias and measurements are
interpolated in regions where no measurements are taken.
Furthermore, cut-off values of EMMparameters to identify areas
with different viability/perfusion/transmurality vary greatly be-
tween studies [15]. Altogether this approach is not reproducible
and prone to errors regarding accurate and detailed identification
of the infarct border zone. Since the non-transmural border zone
of the infarction is believed to be the preferred delivery site of the
stem cell therapeutics [1], it is crucial for it to be optimally
defined during the injection procedure. We hypothesise that
combining the gold standard measure of infarct size and location
by late gadolinium enhanced magnetic resonance imaging
(LGE-MRI) or otherMRI techniques [17] and practical guidance
(NOGA®XP) would further optimize the cell delivery location,
and lead to a uniform injection strategy. This approach enables
accurate selection and targeting of the infarct border zone with a
distinct infarct transmurality with a value between 0 and 100 %.
In this study we describe the development of a practical software
toolbox (3D CartBox) that enables real-time image-guided cell
injections. The 3D CartBox registers NOGA®XP catheter posi-
tions on pre-procedurally acquired MRI images to perform
intramyocardial injections to locations with an a priori identified
distinct infarct transmurality. In addition, the 3D CartBox can be
used to further specify the definition of border zone of the infarct
[8].
Materials and methods
The 3D CartBox is a Matlab-based software toolbox to regis-
ter NOGA®XP catheter positions on an endocardial surface
mesh derived from MRI. Prior to registration two image
processing steps are necessary: 1) Data acquisition, and 2)
Data pre-processing as illustrated in Fig. 1. The 3DCartBox is
used for the registration and consists of three phases: 1) initial
registration, 2) iterative closest point (ICP) registration, and 3)
manual registration. After the registration process post-
processing is performed to visualise the data in bullseye plots.
In the development process described in this study the 3D
CartBox toolbox was applied to data of three pigs with a
chronic myocardial infarction. The study design is illustrated
in Fig. 2. The algorithms used in the 3D CartBox and in the
pre- and post-processing steps are explained in detail in the
supplementary data.
Animals
All experiments were performed in accordance with the
‘Guide for the Care and Use of Laboratory Pigs’ prepared
by the Institute of Laboratory Animal Resources and with
prior approval by the Animal Experimentation Committee of
Fig. 1 Workflow of the image processing steps that are necessary to use
the 3D CartBox toolbox
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the Faculty of Medicine, Utrecht University, the Netherlands.
Three 6-month-old female Dalland Landrace pigs (60–70 kg;
Central Institute for Animal Disease Control (IDDLO),
Lelystad, the Netherlands) were pre-treated with clopidogrel
75mg/day for 3 days and amiodarone 400mg/day for 10 days.
In all pigs myocardial infarction (MI) was induced by 75 min
of percutaneous balloon occlusion of the proximal left circum-
flex coronary artery as previously described [18]. Eight weeks
after MI the experiments were performed as shown in Fig. 2.
Data acquisition
The in vivo MRI images were acquired using a 1.5 T Philips
Medical Systems Achieva scanner. The MRI sequences for
the cine and the LGE MRI acquisitions are described in the
supplementary data. The NOGA® XP system (Biosense
Webster, Cordis, Johnson & Johnson, USA) version 1.1.43
was used equipped with a 7 French NOGA mapping catheter
(Biosense Webster, Cordis, Johnson & Johnson, Diamond
Bar, USA) for the mapping. The left ventricle was entered
via the left carotid artery, and retrograde passage through the
aortic valve. Readout of the catheter tip location was done at
end-diastole using R-wave triggering, thereby providing only
end-diastolic tip locations for registration. Electrocardiograms
were filtered at 30–400 Hz (bipolar) and 1–240 Hz (unipolar).
The EMM datasets were acquired in consideration of the
criteria for good electromechanical mapping [15]. Points ac-
quired in the left and right coronary ostia and the apex served
as anatomical landmarks and are used for the first registration
step. The apex location was taken as the most outward point
that was reached in the apical region confirmed by fluorosco-
py. To obtain data from the NOGA®XP system in a real-time
fashion, the system was modified to enable read-only access
from an external computer running the 3D CartBox.
Data pre-processing
Data pre-processing consists of 1) segmentation of the left
ventricle using the cine images [23], 2) segmentation of the
infarct using the LGE images [24], 3) calculation of the infarct
transmurality, 4) projection of the infarct transmurality on the
endocardial surface mesh derived from the end-diastolic cine
images, and 5) calculation of the infarct transmurality border
zone, the preferred site for cell injections. The details of the
pre-processing steps are described in the supplementary data.
Registration
During initial registration the raw NOGA®XP dataset
and the MRI datasets are registered coarsely based on
the anatomical landmarks using a closed-form least
squares approach [19, 20]. The anatomical landmarks
used are the left and the right coronary ostia and the
apex as previously described [21]. After acquiring
points in all regions of the left ventricular endocardium,
an ICP algorithm [22] was applied to optimise the
registration. If necessary the registration was manually
optimised by adjusting the registration interactively. The
algorithms used for the registration are explained in
detail in the supplementary data. The accuracy of the
registration was expressed by the registration error being
the mean±standard deviation of the shortest distance
from each EMM point to the cine mesh surface as
previously described [21]. The relevance of the registra-
tion error measure used is pointed out in the supple-
mentary data. To prevent interference by EMM points
that were not located in the cine mesh (e.g. left ven-
tricular outflow tract), these points were excluded for
ICP registration, error calculation, and further
processing.
Perioperative image guidance
In this study perioperative registration was performed in two
animals. After initial registration the acquired EMM points
were visualised in the freely rotatable 3D endocardial surface
mesh with projected infarct transmurality data. In addition the
MR images are displayed as shown in Fig. 3e and f. Newly
acquired NOGA®XP measurement points appeared on the
screen. Free rotation of the mesh and the MR images during
the image-guided procedure assures correct positioning of the
needle before cell injection.
Post-processing
For visualisation purposes both the infarct transmurality
values and the infarct border zones, as well as the EMM data,
were projected on the 3D endocardial surface mesh and
bullseye plots using customised software.
Statistical analysis
All data are presented as mean±standard deviation (SD). A
one-way ANOVA test was used to assess the difference be-
tween the number of points/cm2 in the different infarct
transmurality areas. P<0.05 was considered significant.
Fig. 2 Time line of the experiments. The second mapping procedure was
performed in two pigs
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Results
Data pre-processing
MRI findings are listed in Table 1. The mean left ventricular
ejection fraction (LVEF) was 42±1%. All LGE datasets showed
a clear fibrotic area as shown in Fig. 3b. The LVEF shows that
8 weeks after myocardial infarction the pigs had mild heart
failure, and comparable infarct sizes (27.5±3.5 % of total left
ventricular area). The 75–100 % infarct transmurality area was
the smallest, and was absent in one pig. Infarct transmurality was
assessed and subdivided in areas with 0, 0–25, 25–50, 50–75,
and 75–100 % transmurality as illustrated in Fig. 3d. The mean
endocardial surface areas in these subdivisions were: 73.6±19.7,
7.2±1.0, 9.5±2.6, 5.8±2.8, and 4.6±5.2 cm2, respectively, there-
by covering 72.5±5.1, 7.2±0.5, 9.6±2.9, 6.4±4.4, and 4.3±
4.3 % of the total LVendocardial surface area. The locations of
the coronary ostia could be identified on the cine images
(Fig. 3a). In all three pigs we were able to acquire EMM points
in, or in the vicinity of, the coronary ostia. The mean number of
EMM points was 66.3±14.2.
Registration
The registration results are listed in Table 2. Perioperative regis-
tration was performed in two pigs to test the real-time use of the
3D CartBox toolbox (Fig. 2). During the real-time EMM proce-
dures the cine mesh was successfully merged with the EMM
based upon the anatomical landmarks and ICP registration. After
application of ICP the mean surface registration error was 3.27±
1.93mm.Nomanual optimisation of the registration was applied
to the datasets. After exclusion of points located outside the cine
mesh the mean registration error was 3.22±1.86 mm. A cine
mesh with projected infarct transmurality and unipolar voltage
are shown in Fig. 3e and f. Figure 3c shows the corresponding
NOGA®XP EMM. The average coverage of EMM points in the
different infarct transmurality areas was 0.76±0.44 points/cm2.
There was no significant difference between the number of
Fig. 3 Short-axis balanced fast field echo image with coronary ostia (a).
Segmentation of the epicardium (green), endocardium (red), scar area
(yellow) on the short-axis LGE scans (b). NOGA®XP representation of
unipolar voltage map (c). Subdivision of infarct transmurality (d). Infarct
transmurality superimposed on cine mesh. Unipolar voltage projection
superimposed on cine mesh (f). Coloured dots are: NOGA measurement
points (black), the apex (white), annotated location (brown)
Table 1 Results of cine and late enhancement magnetic resonance
imaging of three animals
LV end-diastolic volume (ml) 128±19
LVend-systolic volume (ml) 75±11
LVejection fraction (%) 42±1
Myocardium volume (ml) 118±18
Infarct volume (ml) 17±3
LVarea (cm2) 101±21
Infarct area 0 % transmurality (cm2) 73.6±19.7 (72.5±5.1 %)
Infarct area 0–25 % transmurality (cm2) 7.2±1.0 (7.2±0.5 %)
Infarct area 25–50 % transmurality (cm2) 9.5±2.6 (9.6±2.9 %)
Infarct area 50–75 % transmurality (cm2) 5.8±2.8 (6.4±4.4 %)
Infarct area 75–100 % transmurality (cm2) 4.6±5.2 (4.3±4.3 %)
Data are expressed as mean±SD
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points/cm2 in each infarct transmurality area of all the different
animals (p=0.96).
Post processing
To evaluate the projection of the EMMdata on the endocardial
surface mesh Fig. 4 shows bullseye figures of the unipolar and
bipolar voltage as represented by the NOGA®XP system (a, e)
and after projection on the cine mesh (b, f). Figure 4g repre-
sents the projection of LSS. From the comparison with the
infarct transmurality depicted in Fig. 4c it can be observed that
there is limited agreement between the EMM parameters and
infarct transmurality. The 50 % infarct transmurality border
zone determined by LGE-MRI is projected on the bullseye
figures of the infarct transmurality (c), unipolar voltage (b),
bipolar voltage (f), and linear local shortening (g). From these
images it can be observed that the border zones of low unipo-
lar and bipolar values show alignment with the 50 % infarct
transmurality border zone. Figure 4d and h show the projec-
tion of the 50 % infarct transmurality border zone on the
endocardial surface mesh as it is visualised during image-
guided cell injection procedures.
Discussion
In this study, the feasibility of perioperative integration of electrome-
chanical data acquired with the NOGA®XP systemwithMRI data
was shown for the first time. The in-house developed 3D CartBox
image registration toolbox has allowed us to register the EMM
dataset on a surface mesh derived from end-diastolic cine MRI
images in real time with a mean surface registration error of 3.27±
1.93 mm. The three main findings of this study were: 1) Real-time
use of the toolboxwas feasible; 2) Visually a discrepancywas found
between infarct assessment by EMM and LGE-MRI; 3) The 3D
CartBox toolbox can be of additional value for infarct assessment
and catheter guidance during cardiac cell injection procedures.
Data acquisition and pre-processing
The LVEF in Table 1 showed that 8 weeks after myocardial
infarction the pigs had mild heart failure, and comparable
infarct sizes. The absence of a transmural infarction in one
pig is most likely induced by the different response to the
ischaemia reperfusion procedure due to biological variation.
The number of points in the EMM (66.3±14.2) just fulfilled
the criteria for good electromechanical mapping as published
[15]. During the mapping procedure the EMM points were
acquired homogeneously spread over the endocardium. This
was confirmed by the equal number of points in each area with
a distinct infarct transmurality presented in Table 2, and can be
observed from the distribution of EMM points in Fig. 4.
Registration
Although acquiring more EMM points might have been
beneficial for the registration, the homogeneous distribu-
tion of EMM points over the endocardium has secured a
correct registration. Due to the longer acquisition time of
the LGE images, gated LGE scans did not exactly repre-
sent the end-diastolic phase. To assure use of the end-
diastolic ventricular shape for registration we chose to use
the end-diastolic frame of the cine images for mesh crea-
tion, registration and projection of the EMM data. The
exclusion of EMM points that were not located in the cine
mesh was done to prevent registration based on EMM
points that were located in areas of the left ventricle that
were not visualised with MRI. Of the three cases in this
study totally 9 mapping points were discarded for this
reason. Consequently the registration using all EMM
points has a slightly higher registration error: 3.27±
1.93 mm compared with 3.22±1.86 mm for the map
Table 2 Three-dimensional elec-
tromechanical mapping and im-
age registration results of three
animals
Data are expressed as mean±SD
Electromechanical mapping points
Total number of points 192
Points per animal 66.3±14.2
Distance EMM points to MRI mesh surface (mm)
All EMM points 3.27±1.93 mm based on 192 points
All EMM points in cine mesh 3.22±1.86 mm based on 183 points
Points per infarct transmurality area
0 % 53.3±11.7 0.8±0.3 points/cm2
0–25 % 6.0±3.6 0.8±0.5 points/cm2
25–50 % 6.0±3.0 0.7±0.4 points/cm2 ns (p=0.96)
50–75 % 2.6±1.5 0.4±0.1 points/cm2
75–100 % 4.5±4.1 0.9±1.2 points/cm2
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without the excluded points. Although this difference does
not affect registration, it does prevent erroneous projection
of EMM parameters on the cine mesh. The 10 times
higher weighing of the apex during landmark registration
and restriction of the ICP algorithm to 10° in the sagittal
plane, and 20° in the transverse and coronal planes, were
chosen empirically. The resulting surface registration error
of 3.22±1.86 mm was less than the value reported in
research where CARTO merge was used [21]. The remain-
ing error can be caused by respiratory-induced motion of
the heart during the EMM procedure. The NOGA®XP
system does not compensate for this.
Post-processing
A high similarity is observed between the EMM maps pro-
duced by the NOGA®XP system and the EMM data projected
on the cine mesh. The projection of the EMM data on the
endocardial surface mesh via linear interpolation results in an
accurate projection of the true endocardial surface measure-
ments (Fig. 4a–b and e–f). From visual assessment it can be
inferred that agreement between the infarct identification by
EMM (Fig. 4b, f, e) and LGE-MRI (Fig. 4c) is the best with
unipolar voltage, and poor with both bipolar voltage and linear
local shortening. Although it cannot be ruled out completely,
the small registration error makes it unlikely that this was the
main origin of the poor agreement. Another explanation might
be the occurrence of endocardial conducting tissue in regions
with an infarct, mimicking normal tissue, or extension of the
low voltage regions to neighbouring areas of non-transmural
infarction through interpolation. Acquiring more points dur-
ing the mapping procedure in the border zone may solve this
problem, provided that this area is known, and not susceptible
to arrhythmias due to catheter manipulation. Based on the
rationale that 100 % transmurally infarcted myocardium is
not a location where the stem cells are supplied with sufficient
oxygen and nutrients [1], and in regions with 0 %
transmurality there is no use for stem cells, we have chosen
to show the 50 % infarct transmurality border zone on the
bullseye figures in Fig. 4b, c, d, f, g, h. Visual assessment
shows that the EMM parameters only partly identify the 50 %
infarct transmurality border zone assessed by the gold stan-
dard LGE-MRI infarct assessment technique. The 3D
CartBox toolbox enables accurate targeting of infarct border
zones with a distinct infarct transmurality at any percentage
between 0 and 100 % transmurality determined by LGE-MRI.
Thereby the 3D CartBox, for the first time, enables objective
specification of the target locations for intramyocardial injec-
tions in the context of cardiac regenerative therapy.
Clinical implications
Incorrect injections of stem cells into the myocardium might
jeopardize the success of cardiac regenerative therapy [8]. The
combination of the gold standard fibrosis imaging technique
Fig. 4 Typical bullseye plots of the NOGA system: unipolar voltage (a),
bipolar voltage (e). And data projected on the cine mesh: unipolar voltage
(b), bipolar voltage (f), infarct transmurality (c), linear local shortening
(g). Infarct transmurality and unipolar voltages projected on the endocar-
dial surface mesh placed in an end-diastolic long-axis cine MRI image (d
and h). D and H represent the operator view during the image-guided
injection procedure. Coloured dots are: NOGA measurement points
(black), the apex (white), annotated location (brown). The black overlay
in images b, c, d, f, g, h is a projection of the 50 % infarct transmurality
border zone
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for infarct and infarct border zone identification, and a catheter
navigation technique to guide injections, is a crucial step to
target the infarct border zone more accurately. This approach
could lead to shorter injection procedures, less necessity for
the use of fluoroscopy to confirm the injection location, and
less radiation for the patient and the physician. The workflow
of the 3D CartBox includes: MRI, segmentation, and EMM.
Altogether this takes approximately 3 h, including the injec-
tions. Thereby it is a clinically feasible solution. Real-time
integration of LGE-MRI during cardiac cell injection proce-
dures could be a key to harnessing the full therapeutic effects
of cardiac stem cell therapy. The 3D CartBox toolbox enables
the use of all parameters (perfusion, fibrosis, myocardial wall
thickening, myocardial tissue tagging) from a pre-procedural
acquired MRI or other imaging modality (SPECT/CT) to
guide the cell injection procedures. The 3D CartBox toolbox
for image-guided cardiac cell injections has been awarded the
BioMedical Materials Valorisation Grant, and will be made
commercially available via the newly founded spin-off com-
pany CART-Tech: ‘Technical solutions to improve cardiac
regenerative therapy’.
Limitations
The use of the coronary ostia for landmark registration is
potentially dangerous for the patient and therefore not suitable
for clinical use of the toolbox, although clinical use of this
method has been reported in the literature [21]. For clinical
application of the toolbox in the future we aim to use other
fiducial points. The use of three pigs in this study was found
not to be sufficient to perform a quantitative analysis of the
overlap between the infarct areas identified by EMM and
LGE-MRI or perform a detailed analysis of the thresholds of
the NOGA parameters in the areas with different infarct
transmurality. A new study must be performed to explore
these aspects by applying the 3D CartBox to a larger dataset.
Although the criteria for good electromechanical mapping
were adhered to during all procedures, acquiring more points
might have resulted in a lower registration error. During the
mapping procedure small respiratory-induced excursions of
the catheter tip could be observed. Since the NOGA®XP
system did not compensate for respiratory-induced motion
of the catheter tip, this most likely affected the registration.
Compensation for respiratory motion might be beneficial for
future applications.
Conclusion
We have developed the 3D CartBox toolbox for real-time
registration of EMM and MRI data that combines the gold
standard diagnostic imaging techniques and highly accurate
cardiac navigation to guide cardiac cell injection procedures.
The 3D CartBox toolbox shows promising results but more
research is necessary to specify the optimal injection location
in order to maximise the improvement of cardiac function by
cardiac regenerative therapy.
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